Top Markets
Coin of the day
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
Pozycja w akcjach #38792
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Cena akcji
$0.02
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$801.34K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-18.70%
Kraj
US
Handel Agentix Corp. (AGTX)

Kategoria

Historia stopy dywidendy dla Agentix Corp. (AGTX)
Stopa dywidendy (TTM) dla Agentix Corp. (symbol akcji: AGTX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Agentix Corp. (AGTX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji